Perrie O’tierney Ginn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Perrie O’tierney Ginn has a total of 547 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Michael Catalano
Mother Infant Research Institute, Tufts Medical Center, Boston, MA 02111, USA
4 shared publications - Adam B. Salmon
Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, USA
3 shared publications - Ajoy Aloysius
Department of Biology, University of Kentucky, Lexington, KY 40508, USA
3 shared publications - Akshay Sanghavi
Yuvan Research, Mountain View, CA, USA
3 shared publications - Alexander G. Ophir
Department of Psychology, Cornell University
3 shared publications - Amin Haghani
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA
3 shared publications
Latest Publications
- Open Access
- 13 September 2026
- Published by Springer Nature in Scientific Reports
Paternal but not maternal adiposity is associated with reduced insulin-stimulated glucose uptake in neonatal umbilical cord mesenchymal stromal cells
- 13 September 2026
- Published by Springer Nature in Scientific Reports
Open AccessPaternal but not maternal adiposity is associated with reduced insulin-stimulated glucose uptake in neonatal umbilical cord mesenchymal stromal cells
- Open Access
- 31 March 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (4)
Placental gene signatures associated with high neonatal adiposity: role for immune cell activation
Fetal fat accumulation is an important indicator of the nutritional environment in pregnancy and placental function. Excessive fat accretion leading to high adiposity at birth, however, can increase a child’s long-term risk for obesity and metabolic disease. While maternal body mass index is associated with neonatal adiposity, there is a wide variation in body composition among babies born to both women with and without obesity. The placenta orchestrates a complex exchange of nutrients and signals between the mother and baby. To better understand the molecular mechanisms that govern fetal fat accumulation, we profiled the transcriptomics of 79 placentas collected from mothers with and without obesity. We identified a set of 18 neonatal adiposity-associated genes, common to pregnancies with and without obesity. A co-expressed cluster of these genes are involved in innate immune responses, particularly neutrophil activation. We also identified neonatal adiposity-associated genes unique to mothers with or without obesity, suggesting different biological pathways support high newborn adiposity, and/or are responsive to a common initial immune signal. These findings suggest that placental inflammation may influence fetal fat accumulation. Understanding these pathways may help identify novel ways to support healthy fetal growth and reduce the risk of long-term disease.
- 31 March 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (4)
Open AccessPlacental gene signatures associated with high neonatal adiposity: role for immune cell activation
Fetal fat accumulation is an important indicator of the nutritional environment in pregnancy and placental function. Excessive fat accretion leading to high adiposity at birth, however, can increase a child’s long-term risk for obesity and metabolic disease. While maternal body mass index is associated with neonatal adiposity, there is a wide variation in body composition among babies born to both women with and without obesity. The placenta orchestrates a complex exchange of nutrients and signals between the mother and baby. To better understand the molecular mechanisms that govern fetal fat accumulation, we profiled the transcriptomics of 79 placentas collected from mothers with and without obesity. We identified a set of 18 neonatal adiposity-associated genes, common to pregnancies with and without obesity. A co-expressed cluster of these genes are involved in innate immune responses, particularly neutrophil activation. We also identified neonatal adiposity-associated genes unique to mothers with or without obesity, suggesting different biological pathways support high newborn adiposity, and/or are responsive to a common initial immune signal. These findings suggest that placental inflammation may influence fetal fat accumulation. Understanding these pathways may help identify novel ways to support healthy fetal growth and reduce the risk of long-term disease.
- Open Access
- 28 January 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1736033
Placental mRNA and miRNA dynamics associated with lipid metabolism pathways in pregnancies affected by obesity
Introduction: Maternal obesity (pregravid body mass index >30 kg/m 2 ), which has reached epidemic levels in the US, increases the incidence of cardiovascular disease and all cause premature death in the offspring. The placenta modulates fetal access to lipids and other nutrients and is considered a key player in fetal growth and maturation. However, the complex interplay between dysregulated metabolism in mothers with obesity and placental pathways mediating impacts on fetal development that predispose offspring to morbidities later in life, is poorly understood. Methods: We used unbiased Whole Genome Correlation Network Analysis (WGCNA) in 39 full-term unlabored placentas from mothers affected by obesity to explore relationships between coding and non-coding placental transcripts with maternal and fetal metabolic variables. Results: We identified positive correlations between members of the Rho network, a key inflammation regulator, with maternal leptin and cord blood free fatty acids (cbFFA). Furthermore, we identified negative correlations between epigenetic regulators and the lipid metabolism drivers SMUG1 and CDS1 , with cbFFA. A set of placental miRNAs showed positive correlations with cbFFA. Using mirTarRnaSeq, an R/Bioconductor package, we predicted interactions between placental coding genes and miRNA, which correlated negatively and positively with cbFFA, respectively. Several FFA-associated miRNAs (miR-23b cluster, -168, -138, -6825, -6845) have been previously associated with obesity in animal models and human cohorts. Discussion: Further studies are required to investigate the role that the Rho network plays in placental inflammation and the link between miRNAs and the predisposition towards cardiovascular diseases in the offspring of obese mothers.
- 28 January 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1736033
Open AccessPlacental mRNA and miRNA dynamics associated with lipid metabolism pathways in pregnancies affected by obesity
Introduction: Maternal obesity (pregravid body mass index >30 kg/m 2 ), which has reached epidemic levels in the US, increases the incidence of cardiovascular disease and all cause premature death in the offspring. The placenta modulates fetal access to lipids and other nutrients and is considered a key player in fetal growth and maturation. However, the complex interplay between dysregulated metabolism in mothers with obesity and placental pathways mediating impacts on fetal development that predispose offspring to morbidities later in life, is poorly understood. Methods: We used unbiased Whole Genome Correlation Network Analysis (WGCNA) in 39 full-term unlabored placentas from mothers affected by obesity to explore relationships between coding and non-coding placental transcripts with maternal and fetal metabolic variables. Results: We identified positive correlations between members of the Rho network, a key inflammation regulator, with maternal leptin and cord blood free fatty acids (cbFFA). Furthermore, we identified negative correlations between epigenetic regulators and the lipid metabolism drivers SMUG1 and CDS1 , with cbFFA. A set of placental miRNAs showed positive correlations with cbFFA. Using mirTarRnaSeq, an R/Bioconductor package, we predicted interactions between placental coding genes and miRNA, which correlated negatively and positively with cbFFA, respectively. Several FFA-associated miRNAs (miR-23b cluster, -168, -138, -6825, -6845) have been previously associated with obesity in animal models and human cohorts. Discussion: Further studies are required to investigate the role that the Rho network plays in placental inflammation and the link between miRNAs and the predisposition towards cardiovascular diseases in the offspring of obese mothers.
- Open Access
Maternal Opioids Downregulate Adiponectin Receptor Signaling and Alter Growth in Offspring: Pilot Study
Opioid use disorder (OUD) has been linked to cardiometabolic diseases in adults through reductions in adiponectin—an adipocytokine with insulin–sensitizing effects. Opioid use during pregnancy dysregulates neonatal growth and may predispose to adult–onset diseases, but the impact of maternal OUD on neonatal adiponectin has not been studied. We hypothesize that maternal OUD also reduces adiponectin level in offspring (primary outcome) and alters growth (secondary outcome). To test our hypothesis, we conducted a prospective, observational pilot study and compared the expression of salivary adiponectin receptor 1/ ADIPOR1 and anthropometric and body composition (fat and fat–free mass) measurements between opioid–exposed and age–matched non–exposed neonates born at ≥34 weeks′ gestation. Data were stratified by exposure and sex using a Student′s t–test. Significance was set at pADIPOR1 was reduced in opioid-exposed neonates (0.27–fold, p<0.01), with the lowest expression in those requiring pharmacotherapy (0.048–fold, p<0.001). Despite the smaller anthropometric measurements in the exposed than non–exposed neonates (2915±625 grams vs. 3209±345 grams, p≡0.02), opioid–exposed neonates had comparable adiposity to non–exposed neonates (8.60±4.52% vs. 8.53±4.00%, p≡0.95). Less breast milk was used in the exposed than non–exposed group (25.7% vs. 71.9%, p<0.01). Maternal OUD may be associated with aberrant growth and excess adiposity in offspring through its effect on adiponectin signaling, predisposing these neonates to cardiometabolic risks.
Open AccessMaternal Opioids Downregulate Adiponectin Receptor Signaling and Alter Growth in Offspring: Pilot Study
Opioid use disorder (OUD) has been linked to cardiometabolic diseases in adults through reductions in adiponectin—an adipocytokine with insulin–sensitizing effects. Opioid use during pregnancy dysregulates neonatal growth and may predispose to adult–onset diseases, but the impact of maternal OUD on neonatal adiponectin has not been studied. We hypothesize that maternal OUD also reduces adiponectin level in offspring (primary outcome) and alters growth (secondary outcome). To test our hypothesis, we conducted a prospective, observational pilot study and compared the expression of salivary adiponectin receptor 1/ ADIPOR1 and anthropometric and body composition (fat and fat–free mass) measurements between opioid–exposed and age–matched non–exposed neonates born at ≥34 weeks′ gestation. Data were stratified by exposure and sex using a Student′s t–test. Significance was set at pADIPOR1 was reduced in opioid-exposed neonates (0.27–fold, p<0.01), with the lowest expression in those requiring pharmacotherapy (0.048–fold, p<0.001). Despite the smaller anthropometric measurements in the exposed than non–exposed neonates (2915±625 grams vs. 3209±345 grams, p≡0.02), opioid–exposed neonates had comparable adiposity to non–exposed neonates (8.60±4.52% vs. 8.53±4.00%, p≡0.95). Less breast milk was used in the exposed than non–exposed group (25.7% vs. 71.9%, p<0.01). Maternal OUD may be associated with aberrant growth and excess adiposity in offspring through its effect on adiponectin signaling, predisposing these neonates to cardiometabolic risks.
- Open Access
- 8 September 2025
- Published by Taylor & Francis in BioTechniques
- Vol. 77 (7-8) , 1-12
Impact of ambient temperature exposure on miRNA stability in human plasma
MicroRNAs (miRNAs) are considered more stable than mRNA, but the impact of progressive thawing of biological samples after freezing as may happen during shipping delays has not been quantified. To address this, we utilized digital PCR to estimate the absolute concentrations of select miRNAs following progressive thawing of human plasma and maintenance at ambient temperature. Specifically, we quantified let-7b-3p, miR-144-5p, miR-150-5p, miR-517a-3p, miR-524-5p, and miR-1283, which have varying abundance in plasma. We observed a trend indicating a decline in miRNA concentration as plasma samples were progressively thawed. Notably, miR-150-5p and miR-517a-3p were the least stable and were degraded by 32% and 52% respectively after 24 hours of ambient temperature storage. We found that the variation in sensitivity to temperature was not due to the GC content of the miRNAs nor their initial abundance, suggesting that other factors, such as protein interactors and vesicles carrying these miRNAs, may impact sensitivity.
- 8 September 2025
- Published by Taylor & Francis in BioTechniques
- Vol. 77 (7-8) , 1-12
Open AccessImpact of ambient temperature exposure on miRNA stability in human plasma
MicroRNAs (miRNAs) are considered more stable than mRNA, but the impact of progressive thawing of biological samples after freezing as may happen during shipping delays has not been quantified. To address this, we utilized digital PCR to estimate the absolute concentrations of select miRNAs following progressive thawing of human plasma and maintenance at ambient temperature. Specifically, we quantified let-7b-3p, miR-144-5p, miR-150-5p, miR-517a-3p, miR-524-5p, and miR-1283, which have varying abundance in plasma. We observed a trend indicating a decline in miRNA concentration as plasma samples were progressively thawed. Notably, miR-150-5p and miR-517a-3p were the least stable and were degraded by 32% and 52% respectively after 24 hours of ambient temperature storage. We found that the variation in sensitivity to temperature was not due to the GC content of the miRNAs nor their initial abundance, suggesting that other factors, such as protein interactors and vesicles carrying these miRNAs, may impact sensitivity.
- Open Access
- 6 September 2023
- Published by Springer Nature in Nature Aging
- Vol. 3 (11) , 1462
Author Correction: Universal DNA methylation age across mammalian tissues
- 6 September 2023
- Published by Springer Nature in Nature Aging
- Vol. 3 (11) , 1462
Open AccessAuthor Correction: Universal DNA methylation age across mammalian tissues
- Top Cited Papers
- 11 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 381 (6658) , eabq5693
DNA methylation networks underlying mammalian traits
Using DNA methylation profiles ( n = 15,456) from 348 mammalian species, we constructed phyloepigenetic trees that bear marked similarities to traditional phylogenetic ones. Using unsupervised clustering across all samples, we identified 55 distinct cytosine modules, of which 30 are related to traits such as maximum life span, adult weight, age, sex, and human mortality risk. Maximum life span is associated with methylation levels in HOXL subclass homeobox genes and developmental processes and is potentially regulated by pluripotency transcription factors. The methylation state of some modules responds to perturbations such as caloric restriction, ablation of growth hormone receptors, consumption of high-fat diets, and expression of Yamanaka factors. This study reveals an intertwined evolution of the genome and epigenome that mediates the biological characteristics and traits of different mammalian species.
- 11 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 381 (6658) , eabq5693
Top Cited PapersDNA methylation networks underlying mammalian traits
Using DNA methylation profiles ( n = 15,456) from 348 mammalian species, we constructed phyloepigenetic trees that bear marked similarities to traditional phylogenetic ones. Using unsupervised clustering across all samples, we identified 55 distinct cytosine modules, of which 30 are related to traits such as maximum life span, adult weight, age, sex, and human mortality risk. Maximum life span is associated with methylation levels in HOXL subclass homeobox genes and developmental processes and is potentially regulated by pluripotency transcription factors. The methylation state of some modules responds to perturbations such as caloric restriction, ablation of growth hormone receptors, consumption of high-fat diets, and expression of Yamanaka factors. This study reveals an intertwined evolution of the genome and epigenome that mediates the biological characteristics and traits of different mammalian species.
- Top Cited PapersOpen Access
- 10 August 2023
- Published by Springer Nature in Nature Aging
- Vol. 3 (9) , 1144-1166
Universal DNA methylation age across mammalian tissues
Aging, often considered a result of random cellular damage, can be accurately estimated using DNA methylation profiles, the foundation of pan-tissue epigenetic clocks. Here, we demonstrate the development of universal pan-mammalian clocks, using 11,754 methylation arrays from our Mammalian Methylation Consortium, which encompass 59 tissue types across 185 mammalian species. These predictive models estimate mammalian tissue age with high accuracy (r > 0.96). Age deviations correlate with human mortality risk, mouse somatotropic axis mutations and caloric restriction. We identified specific cytosines with methylation levels that change with age across numerous species. These sites, highly enriched in polycomb repressive complex 2-binding locations, are near genes implicated in mammalian development, cancer, obesity and longevity. Our findings offer new evidence suggesting that aging is evolutionarily conserved and intertwined with developmental processes across all mammals.
- 10 August 2023
- Published by Springer Nature in Nature Aging
- Vol. 3 (9) , 1144-1166
Top Cited PapersOpen AccessUniversal DNA methylation age across mammalian tissues
Aging, often considered a result of random cellular damage, can be accurately estimated using DNA methylation profiles, the foundation of pan-tissue epigenetic clocks. Here, we demonstrate the development of universal pan-mammalian clocks, using 11,754 methylation arrays from our Mammalian Methylation Consortium, which encompass 59 tissue types across 185 mammalian species. These predictive models estimate mammalian tissue age with high accuracy (r > 0.96). Age deviations correlate with human mortality risk, mouse somatotropic axis mutations and caloric restriction. We identified specific cytosines with methylation levels that change with age across numerous species. These sites, highly enriched in polycomb repressive complex 2-binding locations, are near genes implicated in mammalian development, cancer, obesity and longevity. Our findings offer new evidence suggesting that aging is evolutionarily conserved and intertwined with developmental processes across all mammals.